Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
- PMID: 29386945
- PMCID: PMC5683152
- DOI: 10.2147/OAJC.S84097
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
Abstract
In the US, obesity rates are increasing greatly. The Centers for Disease Control and Prevention estimates that 68.5% of Americans, including 63.9% of adult women older than 20 years, are overweight (body mass index between 25 kg/m2 and 29.9 kg/m2) or obese (body mass index >30 kg/m2). In light of this, it is not surprising that the rates of bariatric surgery have also been increasing. When considering the metabolic changes associated with both bariatric surgery and contraceptive use, in combination with the unique medical considerations of obese women, it is indisputable that clear guidelines are needed when counseling obese patients of reproductive age after bariatric surgery. In this literature review, we focus on depot medroxyprogesterone acetate (DMPA) and the implications of its use in obese women, preweight and postweight loss following bariatric surgery. Both DMPA use and bariatric surgery are known to cause bone loss, but it is still unclear whether there is an additive effect of the two factors on bone loss and whether either of these factors directly leads to an increased risk of bone fracture. The current consensus guidelines do not impose a restriction on the use of DMPA after bariatric surgery. DMPA use is associated with weight gain, and it is unclear whether weight loss blunting occurs with the use of DMPA after bariatric surgery. Prior studies had demonstrated an association with weight gain in adolescents, and therefore, those prescribing DMPA use after bariatric surgery in adolescents should proceed with caution. Adult women do not have a similar response to the use of DMPA. DMPA use has rarely been associated with increased risk of venous thromboembolism (VTE). The obesity-associated increase in VTE should be mitigated by surgically induced weight loss. The concurrent use of DMPA in the post bariatric surgical period should not further increase the risk of VTE.
Keywords: DMPA; Depo-Provera; appetite changes; bariatric surgery; bone loss; venous thromboembolism; weight loss blunting.
Conflict of interest statement
Disclosure Clarissa Lam has no conflicts of interest to disclose. Amitasrigowri S Murthy is a trainer for Nexplanon in Merck, a trainer for Mirena in Bayer, and a trainer for Liletta in Actavis. The authors report no other conflicts of interest in this work.
Similar articles
-
Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.Contraception. 1996 Jun;53(6):357-61. doi: 10.1016/0010-7824(96)00085-6. Contraception. 1996. PMID: 8773423 Clinical Trial.
-
Toxicology of depot medroxyprogesterone acetate.Contraception. 1994 Mar;49(3):189-201. doi: 10.1016/0010-7824(94)90037-x. Contraception. 1994. PMID: 8200213 Review.
-
Long-term depot-medroxyprogesterone acetate and bone mineral density.Contraception. 1999 Jan;59(1):25-9. doi: 10.1016/s0010-7824(98)00144-9. Contraception. 1999. PMID: 10342083
-
Weight change in adolescents who used hormonal contraception.J Adolesc Health. 1999 Jun;24(6):433-6. doi: 10.1016/s1054-139x(98)00151-7. J Adolesc Health. 1999. PMID: 10401972
-
[Status of bone mineral density after the long-standing application of contraception Depo-Provera].Ceska Gynekol. 2013 Jan;78(1):116-24. Ceska Gynekol. 2013. PMID: 23607391 Review. Czech.
References
-
- National Center for Health Statistics [webpage on the Internet] Health, United States, 2011, with special feature on socioeconomic status and health [cited April 23, 2013] [Accessed May 2, 2016]. Available from: http://www.cdc.gov/nchs/data/hus/hus11.pdf#069. - PubMed
-
- Maggard MA, Yermilov I, Li Z, et al. Pregnancy and fertility following bariatric surgery: a systematic review. JAMA. 2008;300(19):2286–2296. - PubMed
-
- American College of Obstetricians and Gynecologists ACOG committee opinion No. 549. Obesity in pregnancy. Obstet Gynecol. 2013;121(1):213–217. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources